Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer. [electronic resource]
Producer: 20040226Description: 826-32 p. digitalISSN:- 0724-8741
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Humanized
- Binding Sites -- drug effects
- Cell Line, Tumor -- metabolism
- Cetuximab
- Doxorubicin -- administration & dosage
- Drug Delivery Systems -- methods
- ErbB Receptors -- metabolism
- Humans
- Polyethylene Glycols -- chemistry
- Polyglutamic Acid -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.